Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services
Open Access
- 12 August 2026
- journal article
- research article
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 119 (8) , 225-236
Abstract
Objective: To compare healthcare utilisation and costs for Long COVID (LC) in England and Wales. Design: Case–control cohort analysis with multiple age-, sex-, ethnicity-, deprivation-, region- and comorbidity-matched control groups: (1) COVID-only, no LC; (2) pre-pandemic; (3) contemporary non-COVID and (4) pre-LC (self-controlled, pre-COVID pandemic). Setting: National, population-based, linked UK electronic health records (British Heart Foundation/NHS England Secure Data Environment). Participants: Adults aged ⩾18 years with LC between January 2020 and December 2023. Main outcome measures: Healthcare utilisation (number of consultations/visits per person): primary care (general practitioner (GP)), secondary care (outpatient, inpatient and emergency department, investigations and procedures) and inflation-adjusted cost (£) for LC and control populations. Results: In England ( n = 295,180) and Wales ( n = 7925), LC was associated with higher utilisation and costs across primary and secondary care. Mean annual total cost for LC versus contemporary controls was £6681.6 versus £2039.9 in Wales (3.27-fold) and £3378.3 versus £1355.8 in England (2.49-fold). GP consultations averaged 26.76 (SD 22.07) per person-year in the Welsh LC cohort versus 14.63 (SD 14.34) in England (absolute difference 12.13 visits/year). Cross-national multiplicative difference-in-differences estimates indicated a 25% greater relative LC-related cost increase in Wales compared with England (ratio 1.25, 95% CI 1.09–1.42), corresponding to an absolute excess of £2501 per person-year (95% CI £1707–£3270). Conclusions: LC is associated with sustained increases in healthcare utilisation and costs in England and Wales. Our findings suggest that system-level service design may influence healthcare use and costs following COVID-19, warranting further evaluation of post-viral care models.Keywords
Funding Information
- Programme Grants for Applied Research (COV-LT2-0043)
- British Heart Foundation (SP/19/3/34678)
This publication has 23 references indexed in Scilit:
- Long COVID: a neglected disability in primary careThe Lancet Primary Care, 2025
- Health economic outcomes and national economic impacts associated with Long COVID in England and ScotlandThe European Journal of Health Economics, 2025
- Improving quality in adult long covid services: Findings from the LOCOMOTION quality improvement collaborativeClinical Medicine, 2024
- Integrated care policy recommendations for complex multisystem long term conditions and long COVIDScientific Reports, 2024
- Long COVID: An opportunity to focus on post-acute infection syndromesThe Lancet Regional Health - Europe, 2022
- Long COVID and cardiovascular disease: a learning health system approachNature Reviews Cardiology, 2022
- Attributes and predictors of long COVIDNature Medicine, 2021
- Hierarchical Models for International ComparisonsEpidemiology, 2020
- Toward a science of learning systems: a research agenda for the high-functioning Learning Health SystemJournal of the American Medical Informatics Association, 2014
- Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distributionStatistics in Medicine, 2007